204 related articles for article (PubMed ID: 32931481)
41. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
[TBL] [Abstract][Full Text] [Related]
42. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
Rao AR; Quinones MP; Garavito E; Kalkonde Y; Jimenez F; Gibbons C; Perez J; Melby P; Kuziel W; Reddick RL; Ahuja SK; Ahuja SS
J Immunol; 2003 Nov; 171(9):4875-85. PubMed ID: 14568968
[TBL] [Abstract][Full Text] [Related]
43. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF
Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.
Wu Y; Heinrichs J; Bastian D; Fu J; Nguyen H; Schutt S; Liu Y; Jin J; Liu C; Li QJ; Xia C; Yu XZ
Blood; 2015 Sep; 126(11):1314-23. PubMed ID: 26138686
[TBL] [Abstract][Full Text] [Related]
45. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease.
Sato K; Eizumi K; Fukaya T; Fujita S; Sato Y; Takagi H; Yamamoto M; Yamashita N; Hijikata A; Kitamura H; Ohara O; Yamasaki S; Saito T; Sato K
Blood; 2009 May; 113(19):4780-9. PubMed ID: 19228924
[TBL] [Abstract][Full Text] [Related]
46. Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
Paz K; Flynn R; Du J; Tannheimer S; Johnson AJ; Dong S; Stark AK; Okkenhaug K; Panoskaltsis-Mortari A; Sage PT; Sharpe AH; Luznik L; Ritz J; Soiffer RJ; Cutler CS; Koreth J; Antin JH; Miklos DB; MacDonald KP; Hill GR; Maillard I; Serody JS; Murphy WJ; Munn DH; Feser C; Zaiken M; Vanhaesebroeck B; Turka LA; Byrd JC; Blazar BR
Am J Transplant; 2019 Jun; 19(6):1820-1830. PubMed ID: 30748099
[TBL] [Abstract][Full Text] [Related]
47. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
[TBL] [Abstract][Full Text] [Related]
48. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
49. CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease.
Hequet O; Vocanson M; Saint-Mézard P; Kaiserlian D; Nicolas JF; Bérard F
Am J Transplant; 2004 Jun; 4(6):872-8. PubMed ID: 15147420
[TBL] [Abstract][Full Text] [Related]
50. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
[TBL] [Abstract][Full Text] [Related]
51. The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus.
Choudhury A; Maldonado MA; Cohen PL; Eisenberg RA
J Immunol; 2005 Jun; 174(12):7600-9. PubMed ID: 15944260
[TBL] [Abstract][Full Text] [Related]
52. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
Brown GR; Lee E; Thiele DL
J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480
[TBL] [Abstract][Full Text] [Related]
53. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
54. Immune cell subset counts associated with graft-versus-host disease.
Podgorny PJ; Liu Y; Dharmani-Khan P; Pratt LM; Jamani K; Luider J; Auer-Grzesiak I; Mansoor A; Williamson TS; Ugarte-Torres A; Hoegh-Petersen M; Stewart DA; Daly A; Khan FM; Russell JA; Storek J
Biol Blood Marrow Transplant; 2014 Apr; 20(4):450-62. PubMed ID: 24406506
[TBL] [Abstract][Full Text] [Related]
55. Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
Yamashita K; Choi U; Woltz PC; Foster SF; Sneller MC; Hakim FT; Fowler DH; Bishop MR; Pavletic SZ; Tamari M; Castro K; Barrett AJ; Childs RW; Illei GG; Leitman SF; Malech HL; Horwitz ME
Blood; 2004 May; 103(10):3986-8. PubMed ID: 14764530
[TBL] [Abstract][Full Text] [Related]
56. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
[TBL] [Abstract][Full Text] [Related]
57. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
58. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
[TBL] [Abstract][Full Text] [Related]
59. B-1 cells in systemic autoimmune responses: IgM+, Fc epsilon Rdull B cells are lost during chronic graft-versus-host disease but not in murine AIDS or collagen-induced arthritis.
Iciek LA; Waldschmidt TJ; Griffiths MM; Brooks KH
Immunol Invest; 1994 Aug; 23(4-5):293-311. PubMed ID: 7525472
[TBL] [Abstract][Full Text] [Related]
60. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
Zhang Y; Hexner E; Frank D; Emerson SG
J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
